Targeted Optical Fluorescence Lights Up Lung Cancer
By HospiMedica International staff writers Posted on 19 Aug 2015 |
New intraoperative imaging technology allows for visualization of tumor margins and accurate selection of involved lymph nodes, according to a new study.
Researchers at the University of Pennsylvania (Philadelphia, PA, USA) designed a study to examine the feasibility of using a targeted molecular contrast agent that can bind to lung cancers, which could then be identified using real-time optical imaging during excision surgery. To do so, 50 patients with a biopsy-proven lung adenocarcinoma were enrolled. Before surgery, the patients were administered with 0.1 mg/kg of folate-fluorescein isothiocyanate (FFI), a molecular contrast agent delivered by intravenous (IV) infusion.
FFI binds to folate receptor alpha (FRalpha), a cell surface protein expressed on the exposed surface of adenocarcinoma at a rate of 103–104 receptors per cell; four tumors were not fluorescent, since they did not express FRalpha. During surgery, the tumors were imaged in situ and ex-vivo, after the lung parenchyma was dissected to directly expose the tumor to the imaging system. This was necessary since molecular imaging could identify only seven of the 50 adenocarcinomas in situ, since tumors one centimeter or more below the pleural surface were not detectable until they were removed.
After examining all the excised tissues, the researchers found that the lung adenocarcinomas ranged from 0.3–7.5 cm in diameter, and 92% of them were fluorescent. No false uptake occurred, and in two cases, intraoperative imaging revealed tumor metastases not recognized preoperatively. The researchers found that the most important predictor of success was the distance of the cancerous nodule from the pleural surface. The study was published in the July 2015 issue of the Journal of Thoracic and Cardiovascular Surgery.
“This technology will permit precise visualization of tumor margins, localization of small malignant ground glass opacities, and accurate selection of lymph nodes with metastatic cancer cells. With miniaturization of imaging devices, this method will be particularly useful in minimally invasive surgery,” concluded senior author Sunil Singhal, MD, of the department of surgery, and colleagues. “In the future, with improved devices and molecular contrast agents, this approach may reduce the local recurrence rate and improve intraoperative identification of metastatic cancer cells.”
The researchers also suggested two possible refinements to overcome the 1-cm limitation. The first was using spectroscopic tools to analyze scatter from the fluorescent moiety. Adopting this approach could allow deeper penetration, as much as several centimeters, into the solid organ. The second option was to redesign the tracer for near-infrared (NIR) capabilities. The NIR tracer could then provide greater tissue penetration and reduced autofluorescence, allowing the detection of nodules buried deeper beneath the overlying healthy parenchyma.
Related Links:
University of Pennsylvania
Researchers at the University of Pennsylvania (Philadelphia, PA, USA) designed a study to examine the feasibility of using a targeted molecular contrast agent that can bind to lung cancers, which could then be identified using real-time optical imaging during excision surgery. To do so, 50 patients with a biopsy-proven lung adenocarcinoma were enrolled. Before surgery, the patients were administered with 0.1 mg/kg of folate-fluorescein isothiocyanate (FFI), a molecular contrast agent delivered by intravenous (IV) infusion.
FFI binds to folate receptor alpha (FRalpha), a cell surface protein expressed on the exposed surface of adenocarcinoma at a rate of 103–104 receptors per cell; four tumors were not fluorescent, since they did not express FRalpha. During surgery, the tumors were imaged in situ and ex-vivo, after the lung parenchyma was dissected to directly expose the tumor to the imaging system. This was necessary since molecular imaging could identify only seven of the 50 adenocarcinomas in situ, since tumors one centimeter or more below the pleural surface were not detectable until they were removed.
After examining all the excised tissues, the researchers found that the lung adenocarcinomas ranged from 0.3–7.5 cm in diameter, and 92% of them were fluorescent. No false uptake occurred, and in two cases, intraoperative imaging revealed tumor metastases not recognized preoperatively. The researchers found that the most important predictor of success was the distance of the cancerous nodule from the pleural surface. The study was published in the July 2015 issue of the Journal of Thoracic and Cardiovascular Surgery.
“This technology will permit precise visualization of tumor margins, localization of small malignant ground glass opacities, and accurate selection of lymph nodes with metastatic cancer cells. With miniaturization of imaging devices, this method will be particularly useful in minimally invasive surgery,” concluded senior author Sunil Singhal, MD, of the department of surgery, and colleagues. “In the future, with improved devices and molecular contrast agents, this approach may reduce the local recurrence rate and improve intraoperative identification of metastatic cancer cells.”
The researchers also suggested two possible refinements to overcome the 1-cm limitation. The first was using spectroscopic tools to analyze scatter from the fluorescent moiety. Adopting this approach could allow deeper penetration, as much as several centimeters, into the solid organ. The second option was to redesign the tracer for near-infrared (NIR) capabilities. The NIR tracer could then provide greater tissue penetration and reduced autofluorescence, allowing the detection of nodules buried deeper beneath the overlying healthy parenchyma.
Related Links:
University of Pennsylvania
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery